DOH: Pagtuturok ng AstraZeneca COVID-19 vaccines, itutuloy na

Itutuloy na ng Pilipinas ang pagtuturok ng COVID-19 vaccines na gawa ng Oxford University at British pharmaceutical company na AstraZeneca.

Ito ang sinabi ng Department of Health (DOH) matapos na pansamantalang ipatigil ang pagbabakuna gamit ang naturang vaccine brand.

“Based on current evidence, Vaccine-Induced Thrombosis and Thrombocytopenia (VITT) is a very rare condition of blood clots associated with low platelet counts that can occur 4 to 28 days after receiving a viral vector vaccine such as AstraZeneca,” nakasaad sa statement.

“It was concluded that there are currently no known risk factors for VITT and that the benefits of receiving the vaccine against COVID-19 still outweighs the risk.”

Ayon kay Health Usec. Maria Rosario Vergeire, bunga ng pagpupulong ng ahensya, Food and Drug Administration, at Philippine Society of Hematology and Transfusion Medicine Inc. ang desisyon na ituloy ang pagbabakuna ng AstraZeneca vaccine.

Kung maaalala, sinuspinde ng DOH at Food and Drug Administration noong nakaraang buwan ang pagtuturok ng AstraZeneca vaccines sa mga edad 59-anyos pababa.

Hindi naman naapektuhan ang pagbabakuna ng nasabing vaccine brand sa mga senior citizen.

Kasunod ito ng mga naitalang insidente ng “blood clotting” at mababang platelet count sa ilang nabakunahan sa Europa at Estados Unidos. (Daris Jose)